| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |